Atypical lymphoproliferative disorders: Castleman's disease case report and review of the literature

Tumori

Volumn 90, Issue 3, 2004, Pages 352-355

  Martino, Giovanni ^a,b   Cariati, Sonia ^a   Tintisona, Orlando ^a   Veneroso, Stefano ^a   De Villa, Fabio ^a   Vergine, Massimo ^a   Monti, Massimo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

Angiofollicular lymph node hyperplasia; Atypical lymphocyte proliferation; Castleman's disease

Indexed keywords

ADOLESCENT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CANCER RADIOTHERAPY; CASE REPORT; DEATH; EXCISION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; LYMPH NODE BIOPSY; LYMPHOPROLIFERATIVE DISEASE; PLASMA CELL; REVIEW; SYSTEMATIC REVIEW;

EID: 3242769196     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160409000319     Document Type: Review

References (50)

1. Du MQ, Liu H, Diss TC, Ye H, Hamoudi RA, Dupin N, Meignin V, Oksenhendler E, Boshoff C, Isaacson PG: Kaposi sarcoma-associated herpesvirus infects monotypic (Ig M lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood, 97: 2130-2136, 2001.
2. Yamac K, Senol E, Ataoglu O, Fen T: A case report of multicentric Castleman's disease with simultaneous Epstein-Barr virus infection. Tumori, 87: 342-345, 2001.
3. Hall PA, Donaghy M, Cotter FE, Stanzfeld AG, Levison DA: An immunohistological and genotypic study of the plasma cell form of Castleman's disease. Histopathology, 14: 333-346, 1989.
4. Menke DM, Tieman M, Camoriano JK, Chang S, Madan A, Chow M, Haberman TM, Parwaresh R: Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. Am J Clin Pathol, 105: 268-276, 1996.
5. Castleman B, Iverson L, Menendez VP: Localized mediastinal lynph node hyperplasia resembling thymoma. Cancer, 9: 822-830, 1956.
6. Palestro G, Turrini F, Pagano M, Chiusa L: Castleman's disease. Adv Clin Path, 3: 11-22, 1999.
7. Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, Brennan MF: The management of unicentric and multicentric Castleman's disease. Cancer, 85: 706-717, 1999.
8. Shroff VJ, Gilchrist BF, De Luca FG, McCombs HL, Wesselhoeft CW: Castleman's disease presenting as a pediatric surgical problem. J Pediatr Surg, 30: 745-747, 1995.
9. Day JRS, Bew D, Ali M, Dina R, Smith PLC: Castleman's disease associated with myasthenia gravis. Ann Thorac Surg, 75: 1648-1650, 2003.
10. Van Den Berg M, Pawels P, Jakimowicz JJ, Creemers GJ: Hyaline vascular Castleman's disease: a case report and brief review of the literature. Neth J Med, 60: 444-447, 2002.
11. Nishi J, Maruyama I: Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node. Leuk Lymphoma, 38: 387-394, 2000.
12. Tohda S, Murakami N, Nara N: Human herpesvirus 8 DNA in HIV-negative Japanese patients with multicentric Castleman's disease and related disease. Int J Mol Med, 8: 549-551, 2001.
13. Suda T, Katano H, Delsol G, Kakiuchi C, Nakamura T, Shiota M, Sata T, Higashihara M, Mori S: HHV-8 infection status of AIDS-unrelated and AIDS-associated multicentric Castleman's disease. Pathol Int, 51: 671-679, 2001.
14. Aaron L, Lidove O, Viard JP, Troisvallet D, Piketty C, Vittecoq D, Zucman D, Bletry O, Dupont B: Castleman's disease in patients infected with HIV. Rev Med Interne, 23: 155-163, 2002.
15. Greiner T, Armitage JO, Gross TG: Atypical lymphoproliferative diseases. Hematology, 1: 133-146, 2000.
16. Danon D, Krishnan J, Frizzera G: Morpho-immunophenotypic diversity of Castleman's disease with hyaline vascular type: emphasis on a stromal-rich variant and a new pathogenetic hypothesis. Virchows Arch, 423: 369-382, 1993.
17. Frizzera G: Castleman's disease and related disorders. Semin Diag Pathol, 5: 346-364, 1988.
18. Kitada M, Kusajima K, Kikuchi Y, Sakurada T, Suzuki T, Hirano T: A case of Castleman lymphoma in the right pulmonary hilum and mediastinum. Kyobu Geka, 54: 247-249, 2001.
19. Martino G, Stanzani GL, Cariati S, Elmore U, Tumino G, Zelli GP: Rare peritoneal tumors in the elderly. Report of a case of Castleman's disease. Ann Ital Chir, 66: 521-529, 1995.
20. Sokmen S, Terzi C, Fuzun M, Obuz F, Kargl A: Ileal mesenteric Castleman disease. Eur J Surg, 167: 634-636, 2001.
21. Uzunlar AK, Ozates M, Yaldiz M, Buyukbayram H, Ozaydin M: Castleman's disease in the porta hepatis. Eur Radiol, 10: 1913-1915, 2000.
22. Iyoda A, Yusa T, Hiroshima K, Fujisawa T, Ohwada H: Castleman's disease in the posterior mediastinum: report of a case. Surg Today, 30: 473-476, 2000.
23. Fritsch L, Blondon H, Desvignes G, Schill H, Vilain C, Billey C: Castleman disease localized in the mesentery. J Radiol, 82: 498-500, 2001.
24. Curioni S, D'Amico M, Quartagno R, Martino S, Dell'Antonio G, Cusi D: Castleman's disease with nephritic syndrome, amyloidosis and autoimmune manifestations. Nephrol Dial Transplant, 16: 1475-1478, 2001.
25. Carpentier-Planchon V, Buillanne O, Cabane J, Droulers A, Bodak A: A unique case of destructive polyarthritis associated with multicentric Castleman's disease. Ann Med Intern (Paris), 152: 139-144, 2001.
26. Rohrig G, Engel H, Noack F, Ganser A, Peest D: Multilocular Castleman's disease of the mixed type. A rare differential diagnosis in lymphadenopathy with weakness, weight loss and night-sweats. Dtsch Med Wochenschr, 126: 1070-1072, 2001.
27. De Heer-Groen TA, Prakken AB, Bax NM, Van Dijken PJ: Iron therapy resistant microcytic anaemia in a 13-year-old girl with Castleman's disease. Eur J Pediatr, 155: 1015-1017, 1996.
28. Lachmann HJ, Gilbertson JA, Gillmore JD, Hawkins PN, Pepys MB: Unicenric Castleman's disease complicated by systemic AA amyloidosis: a curable disease. QJM, 95: 211-218, 2002.
29. Altiparmak MR, Pamuk GE, Pamuk ON, Dousoy G: Secondary amyloidosis in Castleman's disease: review of the literature and report of a case. Ann Haemat, 81: 336-339, 2002.
30. Belec L, Salmon-Ceron D, Blanche P, Dreyfus F, Zuber M: POEMS syndrome, multicentric Castleman's disease, renal chromophobe carcinoma and herpes virus type 8 infection. Ann Pathol, 19: 373-374, 1999.
31. Kim TJ, Han JK, Kim YK, Kim TK, Choi BI: Castleman disease of the abdomen: imaging spectrum and clinicopathologic correlations. J Comput Assist Tomogr, 25: 207-214, 2001.
32. Ecklund K, Hartnell GG: Mediastinal Castleman's disease: MR and MRA features. J Thorac Imaging, 9: 156-159, 1994.
33. Okamoto I, Iyonaga K, Fujii K, Mori T, Yoshioka M, Kohrogi H, Matsumoto M, Suga M: Absence of gallium uptake in unicentric and multicentric Castleman's disease. Intern Med, 42: 735-739, 2003.
34. Meyer L, Gibbons D, Ashfaq R, Vuitch F, Saboorian MH: Fine-needle aspiration findings in Castleman's disease. Diagn Cytopathol, 21: 57-60, 1999.
35. Joseph N, Vogelzang RL, Hidvegi D, Neiman HL: Case report: computed tomography of retroperitoneal Castleman's disease. J Comp Assist Tomogr, 9: 570-572, 1985.
36. Yamashita Y, Hirai T, Matsukawa T, Ogata I, Takahashi M: Radiological presentations of Castleman's disease. Comput Med Imaging Graph, 17: 107-117, 1993.
37. Veldhuis GJ, Van Der Leest AHD, De Wolf JTM, De Vries EGE, Vellenga E: A case of localized Castleman's disease with systemic involvement: treatment and pathogenetic aspects. Ann Hematol, 73: 47-50, 1996.
38. Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD: Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer, 92: 670-676, 2001.
39. Sethi T, Joshi K, Sharma SC, Gupta BD: Radiation therapy in the management of giant lymph node hyperplasia. Br J Radiol, 63: 648-650, 1990.
40. Weisenburger DD, Nathwani BN, Winberg CD, Rappaport H: Multicentric angiofollicular lymph node hyperplasia. A clinicopathologic study of 16 cases. Human Pathol, 16: 162-172, 1985.
41. Miller RT, Mukai K, Banks PM, Frizzera G: Systemic lymphoproliferative disorder with morphological features of Castleman's disease. Arch Pathol Lab Med, 108: 626-630, 1984.
42. Schlosnagle DC, Chan WC, Hargreaves HK, Nolting SF, Brynes RK: Plasmacytoma arising in giant lymph node hyperplasia. Am J Clin Pathol, 78: 541-544, 1982.
43. Gerald W, Kostainovsky M, Rosay J: Devolopment of vascular neoplasia in Castleman's disease: report of seven cases. Am J Surg Pathol, 14: 603-614, 1990.
44. Advani R, Warnke R, Rosenberg S: Treatment of multicentric Castleman's disease complicated by the development of non-Hodgkin's lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support. Ann Oncol, 10: 1207-1209, 1999.
45. Fitzpatrick PJ, Brown TC: Angiofollicular lymph node hyperlpasia. Can Med Assoc J, 99: 1259-1262, 1968.
46. Bertero MT, De Maestri M, Calligaris F: Cyclophosphamide vs cyclosporin-A treatment of multicentric Castleman's disease with Kaposi's sarcoma. Haematologica, 85: 216-218, 2000.
47. Pavlidis NA, Skopouli FN, Bai MC, Buorantas CL: A successfully treated case of multicentric angiofollicular hyperplasia with oral chemotherapy (Castleman's disease). Med Pediatr Oncol, 18: 333-335, 1990.
48. Lee FC, Merchant SH: Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide. Am J Hematol, 73: 48-53, 2003.
49. Nishimoto N, Kishimoto T, Yoshizaki K: Anti-interleukin 6 receptor treatment in rheumatic disease. Ann Rheum Dis, 59 (Suppl): 21-27, 2000.
50. Katsume A, Saito H, Yamada Y, Yorozu K, Ueda O, Akamatsu KI, Nishimoto N, Kishimoto T, Yoshizaki K, Ohsugi Y: Anti-interleukin 6 (IL-6) receptor antibody suppresses Castleman's disease like symptoms emerged in IL-6 transgenic mice. Cytokine, 20: 304-311, 2002.